{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:52:09Z","timestamp":1785466329482,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Magdeburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Investigation of risk factors for the presence of vancomycin-resistant enterococci (VRE) in inpatients on surgical wards and associated intensive care units of a German tertiary care hospital.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A single-centre retrospective matched case-control study was performed with surgical inpatients admitted between July 2013 and December 2016. Patients with in-hospital detection of VRE later than 48\u00a0h after admission were included and comprised 116 VRE-positive cases and 116 VRE-negative matched controls. VRE isolates of cases were typed by multi-locus sequence typing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ST117 was identified as the dominant VRE sequence type. Next to length of stay in hospital or on an intensive care unit and previous dialysis the case-control study revealed previous antibiotic therapy as a risk factor for the in-hospital detection of VRE. The antibiotics piperacillin\/tazobactam, meropenem, and vancomycin were associated with the highest risks. After taking into account length of stay in hospital as possible confounder other potential contact-related risk factors such as previous sonography, radiology, central venous catheter, and endoscopy were not significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Previous dialysis and previous antibiotic therapy were identified as independent risk factors for the presence of VRE in surgical inpatients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08238-4","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T13:02:33Z","timestamp":1683032553000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Previous antibiotic therapy as independent risk factor for the presence of vancomycin-resistant enterococci in surgical inpatients. Results from a matched case-control study"],"prefix":"10.1186","volume":"23","author":[{"given":"Philip","family":"MacKenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"F\u00e4rber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Esser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Bechmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Kropf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Croner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Geginat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"8238_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13756-018-0353-x","volume":"7","author":"C Remschmidt","year":"2018","unstructured":"Remschmidt C, Schroder C, Behnke M, Gastmeier P, Geffers C, Kramer TS. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany \u2013 10 years of surveillance. Antimicrob Resist Infect Control. 2018;7:54.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"8238_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.ajkd.2014.05.016","volume":"65","author":"IM Zacharioudakis","year":"2015","unstructured":"Zacharioudakis IM, Zervou FN, Ziakas PD, Rice LB, Mylonakis E. Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance. Am J Kidney Dis. 2015;65(1):88\u201397.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"8238_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0732-8893(99)00136-4","volume":"36","author":"SM Bhavnani","year":"2000","unstructured":"Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis. 2000;36(3):145\u201358.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"8238_CR4","doi-asserted-by":"crossref","unstructured":"Rohde AM, Walker S, Behnke M, Eisenbeis S, Falgenhauer L, Falgenhauer JC et al. Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors-a cross-sectional study in seven German university hospitals from 2014 to 2018. Clin Microbiol Infect. 2022.","DOI":"10.1016\/j.cmi.2022.11.025"},{"issue":"4","key":"8238_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1086\/427512","volume":"191","author":"CA DiazGranados","year":"2005","unstructured":"DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis. 2005;191(4):588\u201395.","journal-title":"J Infect Dis"},{"issue":"3","key":"8238_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1086\/430909","volume":"41","author":"CA DiazGranados","year":"2005","unstructured":"DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41(3):327\u201333.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"8238_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1086\/498903","volume":"42","author":"SA McNeil","year":"2006","unstructured":"McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, Punch JD, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis. 2006;42(2):195\u2013203.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"8238_CR8","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1128\/JCM.36.12.3734-3736.1998","volume":"36","author":"C Wendt","year":"1998","unstructured":"Wendt C, Wiesenthal B, Dietz E, Ruden H. Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry surfaces. J Clin Microbiol. 1998;36(12):3734\u20136.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"8238_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1086\/524331","volume":"29","author":"MK Hayden","year":"2008","unstructured":"Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein RA. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients\u2019 environment. Infect Control Hosp Epidemiol. 2008;29(2):149\u201354.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"8238_CR10","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1128\/JCM.40.6.1963-1971.2002","volume":"40","author":"WL Homan","year":"2002","unstructured":"Homan WL, Tribe D, Poznanski S, Li M, Hogg G, Spalburg E, et al. Multilocus sequence typing scheme for Enterococcus faecium. J Clin Microbiol. 2002;40(6):1963\u201371.","journal-title":"J Clin Microbiol"},{"key":"8238_CR11","volume-title":"Statistics for Epidemiology","author":"NP Jewell","year":"2004","unstructured":"Jewell NP. Statistics for Epidemiology. Boca Raton, US: Chapman and Hall\/CRC; 2004."},{"key":"8238_CR12","doi-asserted-by":"publisher","first-page":"i969","DOI":"10.1136\/bmj.i969","volume":"352","author":"N Pearce","year":"2016","unstructured":"Pearce N. Analysis of matched case-control studies. BMJ. 2016;352:i969.","journal-title":"BMJ"},{"key":"8238_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13756-018-0394-1","volume":"7","author":"S Kampmeier","year":"2018","unstructured":"Kampmeier S, Kossow A, Clausen LM, Knaack D, Ertmer C, Gottschalk A, et al. Hospital acquired vancomycin resistant enterococci in surgical intensive care patients - a prospective longitudinal study. Antimicrob Resist Infect Control. 2018;7:103.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"8238_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ajic.2008.04.260","volume":"37","author":"MJ Cohen","year":"2009","unstructured":"Cohen MJ, Adler A, Block C, Gross I, Minster N, Roval V, et al. Acquisition of vancomycin-resistant enterococci in internal medicine wards. Am J Infect Control. 2009;37(2):111\u20136.","journal-title":"Am J Infect Control"},{"issue":"3","key":"8238_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jhin.2016.07.023","volume":"94","author":"N Monteserin","year":"2016","unstructured":"Monteserin N, Larson E. Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. J Hosp Infect. 2016;94(3):236\u201341.","journal-title":"J Hosp Infect"},{"issue":"6","key":"8238_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s15010-014-0678-1","volume":"42","author":"M Papadimitriou-Olivgeris","year":"2014","unstructured":"Papadimitriou-Olivgeris M, Drougka E, Fligou F, Kolonitsiou F, Liakopoulos A, Dodou V, et al. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients. Infection. 2014;42(6):1013\u201322.","journal-title":"Infection"},{"issue":"10","key":"8238_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.ajic.2014.06.024","volume":"42","author":"E Jung","year":"2014","unstructured":"Jung E, Byun S, Lee H, Moon SY, Lee H. Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization. Am J Infect Control. 2014;42(10):1062\u20136.","journal-title":"Am J Infect Control"},{"key":"8238_CR18","first-page":"Doc06","volume":"16","author":"MT Bui","year":"2021","unstructured":"Bui MT, Rohde AM, Schwab F, M\u00e4rtin N, Kipnis M, Boldt AC, et al. Prevalence and risk factors of colonisation with vancomycin-resistant Enterococci faecium upon admission to Germany\u2019s largest university hospital. GMS Hyg Infect Control. 2021;16:Doc06.","journal-title":"GMS Hyg Infect Control"},{"issue":"2","key":"8238_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4040\/jkan.2013.43.2.287","volume":"43","author":"SJ Byun","year":"2013","unstructured":"Byun SJ, Kang J. [Risk factors and clinical outcomes for vancomycin-resistant enterococcus colonization on intensive care unit admission]. J Korean Acad Nurs. 2013;43(2):287\u201395.","journal-title":"J Korean Acad Nurs"},{"issue":"1","key":"8238_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/2047-2994-1-31","volume":"1","author":"S Karki","year":"2012","unstructured":"Karki S, Houston L, Land G, Bass P, Kehoe R, Borrell S, et al. Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resist Infect Control. 2012;1(1):31.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"8238_CR21","doi-asserted-by":"publisher","first-page":"e00473","DOI":"10.1016\/j.heliyon.2017.e00473","volume":"3","author":"N Ulrich","year":"2017","unstructured":"Ulrich N, Vonberg RP, Gastmeier P. Outbreaks caused by vancomycin-resistant Enterococcus faecium in hematology and oncology departments: a systematic review. Heliyon. 2017;3(12):e00473.","journal-title":"Heliyon"},{"issue":"8\u201309","key":"8238_CR22","first-page":"624","volume":"83","author":"L Sommer","year":"2021","unstructured":"Sommer L, Hackel T, Hofmann A, Hoffmann J, Hennebach E, K\u00f6pke B, et al. [Multi-Resistant Bacteria in patients in Hospitals and Medical Practices as well as in residents of nursing Homes in Saxony - results of a Prevalence Study 2017\/2018]. Gesundheitswesen. 2021;83(8\u201309):624\u201331.","journal-title":"Gesundheitswesen"},{"issue":"2","key":"8238_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1086\/338234","volume":"34","author":"EM D\u2019Agata","year":"2002","unstructured":"D\u2019Agata EM, Gautam S, Green WK, Tang YW. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis. 2002;34(2):167\u201372.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"8238_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1086\/502081","volume":"23","author":"CJ Donskey","year":"2002","unstructured":"Donskey CJ, Hoyen CK, Das SM, Helfand MS, Hecker MT. Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol. 2002;23(8):436\u201340.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"26","key":"8238_CR25","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJM200012283432604","volume":"343","author":"CJ Donskey","year":"2000","unstructured":"Donskey CJ, Chowdhry TK, Hecker MT, Hoyen CK, Hanrahan JA, Hujer AM, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med. 2000;343(26):1925\u201332.","journal-title":"N Engl J Med"},{"key":"8238_CR26","doi-asserted-by":"crossref","unstructured":"Correa-Martinez CL, Stollenwerk VB, Kossow A, Schaumburg F, Mellmann A, Kampmeier S. Risk Factors for Long-Term Vancomycin-Resistant Enterococci Persistence-A Prospective Longitudinal Study. Microorganisms. 2019;7(10).","DOI":"10.3390\/microorganisms7100400"},{"issue":"8","key":"8238_CR27","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1469-0691.2008.02026.x","volume":"14","author":"EI Kritsotakis","year":"2008","unstructured":"Kritsotakis EI, Christidou A, Roumbelaki M, Tselentis Y, Gikas A. The dynamic relationship between antibiotic use and the incidence of vancomycin-resistant Enterococcus: time-series modelling of 7-year surveillance data in a tertiary-care hospital. Clin Microbiol Infect. 2008;14(8):747\u201354.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"8238_CR28","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1086\/382086","volume":"189","author":"LB Rice","year":"2004","unstructured":"Rice LB, Hutton-Thomas R, Lakticova V, Helfand MS, Donskey CJ. Beta-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci. J Infect Dis. 2004;189(6):1113\u20138.","journal-title":"J Infect Dis"},{"issue":"50","key":"8238_CR29","first-page":"858","volume":"114","author":"C Remschmidt","year":"2017","unstructured":"Remschmidt C, Schneider S, Meyer E, Schroeren-Boersch B, Gastmeier P, Schwab F. Surveillance of antibiotic use and resistance in Intensive Care Units (SARI). Dtsch Arztebl Int. 2017;114(50):858\u201365.","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"8238_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/clinids\/23.4.767","volume":"23","author":"NG Tornieporth","year":"1996","unstructured":"Tornieporth NG, Roberts RB, John J, Hafner A, Riley LW. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis. 1996;23(4):767\u201372.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"8238_CR31","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1590\/S1517-838246320140403","volume":"46","author":"D Moemen","year":"2015","unstructured":"Moemen D, Tawfeek D, Badawy W. Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University Hospitals intensive care units, Egypt. Braz J Microbiol. 2015;46(3):777\u201383.","journal-title":"Braz J Microbiol"},{"issue":"8","key":"8238_CR32","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3201\/eid0808.010418","volume":"8","author":"Y Carmeli","year":"2002","unstructured":"Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis. 2002;8(8):802\u20137.","journal-title":"Emerg Infect Dis"},{"key":"8238_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13756-015-0064-5","volume":"4","author":"C Forstner","year":"2015","unstructured":"Forstner C, Diab-Elschahawi M, Kivaranovic D, Graninger W, Mitteregger D, Macher M, et al. Non-linear significant relationship between use of glycopeptides and isolation of vancomycin-resistant Enterococcus species in a university hospital setting. Antimicrob Resist Infect Control. 2015;4:25.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"7","key":"8238_CR34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1086\/666331","volume":"33","author":"JA McKinnell","year":"2012","unstructured":"McKinnell JA, Kunz DF, Chamot E, Patel M, Shirley RM, Moser SA, et al. Association between vancomycin-resistant Enterococci bacteremia and ceftriaxone usage. Infect Control Hosp Epidemiol. 2012;33(7):718\u201324.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"8238_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13756-017-0253-5","volume":"6","author":"C Remschmidt","year":"2017","unstructured":"Remschmidt C, Behnke M, Kola A, Pena Diaz LA, Rohde AM, Gastmeier P, et al. The effect of antibiotic use on prevalence of nosocomial vancomycin-resistant enterococci- an ecologic study. Antimicrob Resist Infect Control. 2017;6:95.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"8","key":"8238_CR36","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1017\/S0950268815003118","volume":"144","author":"AMJ Kunz","year":"2016","unstructured":"Kunz AMJ, Moser DF, Vangala SA, Tseng S, Shapiro CH. Patient-level analysis of incident vancomycin-resistant enterococci colonization and antibiotic days of therapy. Epidemiol Infect. 2016;144(8):1748\u201355.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"8238_CR37","first-page":"CD003543","volume":"2","author":"P Davey","year":"2017","unstructured":"Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;2(2):CD003543.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"8238_CR38","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1016\/S1473-3099(17)30325-0","volume":"17","author":"D Baur","year":"2017","unstructured":"Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, D\u00f6bele S, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(9):990\u20131001.","journal-title":"Lancet Infect Dis"},{"key":"8238_CR39","doi-asserted-by":"publisher","first-page":"100732","DOI":"10.1016\/j.drup.2020.100732","volume":"53","author":"G Werner","year":"2020","unstructured":"Werner G, Neumann B, Weber RE, Kresken M, Wendt C, Bender JK, et al. Thirty years of VRE in Germany - \u201cexpect the unexpected\u201d: the view from the National Reference Centre for Staphylococci and Enterococci. Drug Resist Updat. 2020;53:100732.","journal-title":"Drug Resist Updat"},{"issue":"12","key":"8238_CR40","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1093\/cid\/ciab001","volume":"73","author":"L El Haddad","year":"2021","unstructured":"El Haddad L, Hanson BM, Arias CA, Ghantoji SS, Harb CP, Stibich M, et al. Emergence and transmission of Daptomycin and Vancomycin-Resistant Enterococci between Patients and Hospital rooms. Clin Infect Dis. 2021;73(12):2306\u201313.","journal-title":"Clin Infect Dis"},{"key":"8238_CR41","doi-asserted-by":"crossref","unstructured":"Gorrie C, Higgs C, Carter G, Stinear TP, Howden B. Genomics of vancomycin-resistant Enterococcus faecium. Microb Genom. 2019;5(7).","DOI":"10.1099\/mgen.0.000283"},{"issue":"7","key":"8238_CR42","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1128\/JCM.00258-17","volume":"55","author":"JM Fonville","year":"2017","unstructured":"Fonville JM, van Herk CMC, Das PHAC, van de Bovenkamp JHB, van Dommelen L. A single negative result for. J Clin Microbiol. 2017;55(7):2261\u20137.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08238-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08238-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08238-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T13:03:42Z","timestamp":1683032622000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08238-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8238"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08238-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"29 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The implementation of the present case-control study was reviewed and approved by the Ethics Committee of the University Hospital Magdeburg (file number 126\/17, approval date 24.08.2017). The requirement for informed consent was waived by the Ethics Committee of the University Hospital Magdeburg because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no financial and non-financial competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"274"}}